OCT Biomarkers in Ocular CLN2 Disease in Patients Treated With Intraventricular Enzyme Replacement Therapy
Биомаркеры ОКТ при офтальмологическом заболевании CLN2 у пациентов, получающих интравентрикулярную ферментозаместительную терапию
2024-07-30
SCID: 54.1/aw92hrqf
Discuss with AI
CLN2 diseaseellipsoid zone lossenzyme replacement therapyoptical coherence tomographyphotoreceptor degeneration
Figures from the paper
Abstract (AI)
Purpose: Bilateral progressive, symmetrical loss of central retinal thickness (CRT) has been described in neuronal ceroid lipofuscinosis type 2 (CLN2) disease. This study details the pattern of morphological changes underlying CRT loss and disease progression in patients receiving intracerebroventricular (ICV) enzyme replacement therapy (ERT) with cerliponase alfa. Methods: Spectral-domain optical coherence tomography macular cube scans were collected from 16 patients with classic CLN2 disease receiving ICV ERT. Detailed retinal structure analyses were performed on manually segmented horizontal B-scans through the fovea to determine the thickness of six retinal parameters and the extent of ellipsoid zone (EZ) loss. Results: Anatomical changes primarily occurred in photoreceptor (PR)-related retinal parameters and correlated with ocular disease severity. Retinal degeneration began with initial focal parafoveal EZ discontinuities signaling the onset of rapid PR degeneration in a predictable pattern: parafoveal PR involvement with foveal sparing followed by profound parafoveal and foveal PR loss with additional thinning beyond the central retina. PR degeneration began with outer segment loss and progressed to outer nuclear layer (ONL) involvement. Longitudinal analyses confirmed these observations. The rate of PR loss was fastest at the fovea at ∼58 mm per year and became slower at locations farther away from the fovea. Conclusions: Retinal degeneration in CLN2 disease is primarily associated with PR loss in a predictable pattern, with EZ disruption signaling early PR stress. CRT, ONL thickness, and PR layer thickness are useful anatomical biomarkers for understanding disease progression and treatment efficacy in CLN2. Studies using en face images will further clarify CLN2-related retinal degeneration.
Key Findings
1
Central retinal thickness, outer nuclear layer thickness, and photoreceptor-layer thickness are useful anatomical biomarkers for monitoring CLN2 progression and treatment efficacy.
2
Disease progression began with focal parafoveal ellipsoid-zone discontinuities, followed by predictable photoreceptor degeneration with initial foveal sparing.
3
In 16 patients with classic CLN2 disease receiving intraventricular cerliponase alfa, retinal degeneration primarily involved photoreceptor-related retinal structures.
4
Photoreceptor loss progressed from outer-segment degeneration to involvement of the outer nuclear layer, eventually affecting parafoveal and foveal regions.
5
Photoreceptor loss was fastest at the fovea, approximately 58 mm per year, and slowed at locations farther from the fovea.
Research Object
Retinal degeneration in patients with classic neuronal ceroid lipofuscinosis type 2 (CLN2) receiving intraventricular enzyme replacement therapy
Research Subject
The predictable spatial and longitudinal pattern of photoreceptor and ellipsoid-zone loss, retinal thinning, and their utility as biomarkers of ocular disease progression and treatment efficacy
Publication Details
Publication Date
2024-07-30
Journal
Publisher
ISSN
Cited by
3
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Spectrum of Ocular Manifestations in CLN2-Associated Batten (Jansky-Bielschowsky) Disease Correlate with Advancing Age and Deteriorating Neurological Function2013
Symmetric Age Association of Retinal Degeneration in Patients with CLN2-Associated Batten Disease2020
Visual perception and macular integrity in non-classical CLN2 disease2022